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Introduction
Prostate cancer (PCa) is currently the second leading cause of death in men in the United States (Adlercreutz 1990) . A recent emphasis on the role of diet in cancer prevention and treatment has identified several compounds as beneficial in limiting carcinogenesis. More specifically, epidemiologic studies have linked diets rich in cruciferous vegetables, such as broccoli, Brussels sprouts, and cauliflower, with a marked reduction in PCa risk (Hebert et al. 1998; Giovannucci et al. 2003) . Sulforaphane (SFN), an isothiocyanate metabolic by-product of glucoraphanin, appears to be the primary bioactive compound responsible for this effect (Bhamre et al. 2009) . SFN has been shown to play an important role in inducing antioxidant electrophile response defense (phase 2) enzymes in PCa cells (Brooks et al. 2001) , and is also associated with significant changes in expression of genes involved in the regulation of cell growth and cell cycle (Bhamre et al. 2009; Shan et al. 2006) . Investigation of the role and effects of SFN on various types of cancer has led to the identification of several genes whose expression is affected by SFN treatment (for review, see Juge et al. 2007) . SFN has been shown to inhibit prostate cancer (PCa) cell proliferation in a p53-independent manner (Fimognari et al. 2006) , making it an attractive agent to treat tumors with mutated p53. This anti-proliferative activity of SFN has been correlated with increased expression of tumor suppressor and cyclin-dependent kinase inhibitor p21 CIP1 . Taken together, the interpretation of these findings suggests that SFN activity may exert itself through induction of apoptosis and regulation of cell growth arrest (Chiao et al. 2002) . In addition to these roles, at physiologically significant concentrations (5 to 15 µM), SFN has been shown to be involved in epigenetic regulation of gene expression through its Histone DeACetylase (HDAC) inhibitor activity (Dashwood et al. 2008) , as well as potentially affecting DNA methylation (Hsu et al. 2011 ). In addition, SFN-induced increase in acetylation of histones H3 and H4 has been correlated with increased expression of important genes such as p21 CIP1 and Bax (Wang et al. 2008 ).
The maintenance or attrition of telomeres plays an important role in cell proliferation, processes involved in differentiation, and senescence (Liu et al. 2004; Kyo et al. 2008) . Loss of control in this process and re-activation of telomere elongation mediated by TElomerase Reverse-Transcriptase (TERT) can eventually lead to cellular immortality and carcinogenesis in a large number of human cancers making it an important potential target for therapy.
The high expression level of TERT in human cancer cells, the catalytic sub-unit of the telomerase complex conferring D r a f t 4 type-specific (Devereux et al. 1999; Guilleret et al. 2002) and may not be the most reliable marker to investigate TERT activation or repression. Histone N-termini acetylation and methylation are also involved in transcriptional regulation of human TERT (hTERT) (Cong et al. 2000) . Importantly, a recent study using several breast cancer cell lines has demonstrated that SFN represses hTERT transcriptional expression by modulating various active and inactive histone markers over the hTERT promoter region (Meeran et al. 2010) . Based on this evidence and the demonstration that specific histone post-translational modifications can be used as predictors of PCa risk (Seligson et al. 2005) combined with the reported HDAC inhibitor activity of SFN we decided to investigate the interactions of various epigenetic events that can regulate hTERT expression. Our studies revealed that hTERT regulation in PCa cells is highly complex and requires, not only, cross talk between histone post-translational modifications and but was also affected by the recruitment of chromatin-associated proteins (CAP) to regulate the recruitment of specific transcription factors. In addition to these results confirming standard epigenetic modifications as important players, we provide evidence suggesting that chromatin structure (nucleosome "density" and compaction) has a significant impact on the regulation of hTERT expression.
Materials and Methods
Cell culture:
The prostate cancer cell lines LNCaP (androgen-dependent) and fluorescence values from the collected samples to that generated from a standard curve obtained using a 10-fold dilution of TRS8 template (provided as control in the kit). Heat-treated samples were used as telomerase negative control. The positive control data were obtained using a TSK template (provided in the TRAPEZE RT kit). All telomerase activity measurements were performed in triplicate. The normalization of the data was performed as described in the manual of the Trapeze RT Telomerase Detection Kit protocol.
Nucleosome Repeat Length (NRL) Assay:
20-50 µg of isolated nuclei +/-SFN treatment were digested with 5 units of Micrococcal Nuclease (MNase) for 1, 5, and 10 minutes at room temperature as described in Becker and Wu (Becker and Wu 1992) . The digested chromatin samples were then treated with RNase 1 and digested with proteinase K (Roche), followed by organic extraction, and ethanol precipitated as described in Becker and Wu Becker and Wu 1992) . Gel electrophoresis of the digested products was performed in 1% agarose in 1×TAE, next to a molecular weight marker containing a 100-bp ladder. After electrophoresis and ethidium bromide staining, the global average Nucleosome Repeat Lengths (NRL)
were determined as described by Rodriguez-Campos and coworkers (Rodriguez-Campos et al. 1989 ) by measuring the distances of migration of the band corresponding to tetranucleosomes. It is important to note that repeat lengths are best evaluated using measurement from oligonucleosomes (we selected the tetranucleosome as a standard) to minimize the contribution of end trimming by MNase (Blank and Becker 1995 Table S2 ) according to the provider's instruction. The complexes were precipitated using Dynabeads protein-G beads (Invitrogen, Cat# 100.04D). The control ChIP was performed using IgG. The primers used for qPCR amplification are listed in Supplementary Table S3 . After proper washes, the IP-ed material was incubated over-night at 65 o C in presence of 10 µg of RNase 1 and 40 mM NaCl to reverse the cross-links. The material was then ethanol precipitated and deproteinized using 10 µg of proteinase K (Roche). After phenol/Chloroform extraction followed by two ethanol precipitations performed in presence of 10 µg of glycogen used as carrier, the samples were air-dried and re-suspended in 30 µl of water. The qPCR was performed in 96-well plates with Power SYBR® Green Master Mix (Life Technologies). Primers for qPCR were designed using the free open-source software Primer3
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi).
Statistical Analysis:
All experiments were done in triplicate and analyzed using appropriate statistical methods. One-way ANOVA was used followed by Dunnett's multiple comparison Test for the SFN concentration dependence studies. For the time dependent studies and cell-cycle analysis, we used two-way ANOVA followed by Bonferroni Post-test. The Student's t-test was used for comparing each experimental treatment value (SFN) against the corresponding control value.
Standard notation was used to denote significant p-values: *p<0.05, **p<0.01, ***p<0.001. To investigate SFN's effect on telomerase transcription, we monitored mRNA levels of hTERT after 24 hours of SFN treatment (15 µM) by qRT-PCR. As a control, we also monitored expression of NF-κB, which has been shown to be repressed by SFN in PC3 PCa cell (Xu et al. 2005) . Our results indicated a ~35-fold repression of hTERT mRNA transcription in LNCaP, and ~25-fold in DU-145 (Figure 1-A) . SFN treatment caused a 20-fold decrease in NF-κB mRNA in LNCaP, and ~32-fold in DU-145 ( Fig. 1-A 
Results
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d. Potential role of the chromatin-associated protein MeCP2 in SFN-dependent hTERT regulation of transcription:
In order to further strengthen our understanding of the chromatin folding-related element, we decided to investigate the role of MeCP2, a chromatin-associated protein that has been linked with both chromatin compaction (Georgel et al. 2003) , interaction with specific histone PTM (El-Osta et al. 2002) , and prostate cancer cell growth (Bernard et al. 2006 ). Our results showed that SFN treatment significantly decreased MeCP2 expression at the protein level in LNCaP As we attempted to pinpoint the epigenetic mechanism(s) by which SFNdependent hTERT repression is mediated, we identified a combination of specific histone PTMs (post-translational modifications) known to be involved in evaluating the risk of PCa recurrence (H3K4me2, H3K18Ac, (Seligson et al. 2005; ), a chromatin-associated protein (MeCP2 (Georgel et al. 2003) ), and changes in chromatin architecture as important factors in that process.
Histone post-translational modifications
Global changes: SFN treatment induces global changes in two of the histone PTMs described as related to PCa recurrence (Seligson et al. 2005; (Pinskaya et al. 2009a (Pinskaya et al. , 2009b . These two histone PTMs can also be associated with a delayed or poor recruitment of RNA pol II (Pinskaya et al. 2009a (Pinskaya et al. , 2009b , which would result in a lower level of expression of the gene(s) affected. Several genes have also been demonstrated to have increased H3K18Ac, and yet be thoroughly repressed (Smith 2008; Barber et al. 2012; Kelly et al. 2013) . Another study by Meeran and colleagues indicates that SFN increased the level of pan-H3Ac, pan-H4Ac, and H3K9Ac (active markers); whereas decreased the level of H3K9me3 and H3K27me3 (inactive markers) at hTERT promoter region (Meeran et al. 2010 ). This modulation of chromatin at regulatory regions of hTERT gene by SFN may facilitate the binding of various repressor proteins.
Chromatin architecture
Distribution of nucleosomes:
The NRL decreases observed in response to SFN treatment in LNCaP were localized as overlapping with hTERT promoter region and early-transcribed region. The NRL prior to SFN treatment suggests that The recruitment of MeCP2 over these sections of the promoter and the hTERT early-transcribed region does not appear to be directly mediated by the presence of methylated CpG, as none were detected under our experimental conditions.
In this case, MeCP2 recruitment would be mediated by its ability to specifically associate with certain histone PTMs (Thambirajah et al. 2012 ) that can be indicative of either active (H3K4me2/3, H3K9/14Ac) or repressive (H3K9me2/3, H3K27me3). Our result suggests that MeCP2 binding was increased by the augmented presence of H3K4me2 (Regions -744 to -344 and -56 to +1643, Figure 3 -B) in DU-145, leading to heterochromatinization (as shown by decreased NRL, Figure 4 ; hTERT 3' Prom & ETR). Note that recent evidence has led to a re-evaluation of the role of H3K4me2 and H3K4me3 in promoter activation (Pinskaya et al. 2009a (Pinskaya et al. , 2009b . These two histone PTMs can also be associated with a delayed or poor recruitment of RNA pol II (Pinskaya et al. 2009a (Pinskaya et al. , 2009b , which would result in a lower level of expression of the gene(s) affected. Our results are consistent with the recruitment of MeCP2 acting as a contextdependent transcriptional mediator (Thambirajah et al. 2012) . The apparently conflicting results may be associated with specific cell types (telomerase-negative vs. telomerase-positive (Devereux et al. 1999; Guilleret et al. 2002; Liu et al. 2004 ) and androgen-dependent vs. androgen-insensitive.
Based on our reported results and published data, it appears that the mechanism by which SFN can repress hTERT transcription is more complex than anticipated, involving more than a simple change in histone acetylation level mediated by SFN treatment. Multiple epigenetic events (local distribution of histone PTMs, chromatin composition and structure) over the hTERT promoter and early-transcribed region are involved that will mediate the accessibility of transcription factors to their cognate binding sites. Based on the correlation between nucleosome distribution and potential folding and increased presence of specific histone PTM H3K4me2, we believe that the transcription factor and chromatin compactor MeCP2 play an important role in the SFN-mediated hTERT repression. Immunoblots for H3 Pan-acetylated (Pan Ac), H4 Pan acetylated, H3K9Ac, H3K18 Ac, and H3K4me2 were performed in triplicate using whole cell lysates. Quantification was performed after densitometry scanning and normalization to the GAPDH loading control. hours. The blots were stripped and re-probed using a β-actin antibody to normalize for differences in loading.
B. The relative expression levels were determined by densitometric scanning of each band and normalized to the β- The location of MeCP2 was assessed by ChIP followed by qPCR analysis of the precipitated DNA fragments. The primers used for analysis are listed in Supplementary Table S3 . The x-axis shows the location (in bp) of the amplicons.
The y-axis shows the % increase in signal observed after SFN treatment. Each experiment was performed in triplicate.
A Supplementary Table S3 . The x-axis shows the location (in bp) of the amplicons. The y-axis shows the % change in signal observed after SFN treatment. Each experiment was performed in triplicate. A generalized outline of the hTERT promoter and early transcribed regions is shown depicting the location of the known transcription factor binding sites (ER, -2677/-2665 and -863/-859; VDR, -2530 VDR, - /-2516 Sp1, -873/-868, -110/-102, -88/-83, -56/-48, -36 /-28 and -7/-2; MZF-2, -687/-680, -619/-612, -543/-536 and -514/-507; WT1, -281/-273; E2F, -174/-170 and -98/-94; E-box, -165/-160 and +44/+49; ER81, +288/+291 and +390/+393). *p<0.05, **p<0.01, ***p<0.001. A. ChIP experiment using LNCaP cells. B. ChIP experiment using DU-145 cells. 172x103mm (300 x 300 DPI)
